Active-ingredient Dossier
Influenza Virus Haemagglutinin
Active-ingredient Dossier for Influenza Virus Haemagglutinin (inactivated influenza vaccine). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: Audenz
- Brand: Celldemic
- Brand: INFLUVAC
- Brand: FLUCELVAX
- Brand: FLUZONE
- Brand: VAXIGRIP
- Therapeutic area: Infectious Disease
What is
Influenza Virus Haemagglutinin Influenza Virus Haemagglutinin is an inactivated influenza vaccine.
Australian brands containing
Influenza Virus Haemagglutinin — FLUAD — Audenz — Celldemic — FLUCELVAX — FluQuadri — FLUZONE — FLUARIX TETRA — CSL Bulk — AFLURIA QUAD — INFLUVAC — VAXIGRIP — Panvax
Therapeutic areas
Influenza Virus Haemagglutinin is registered in Infectious Disease (7 brands), Complementary Medicine (4 brands), and Immunology (4 brands).
Sponsor landscape
The ingredient is marketed by four sponsors: Seqirus, Sanofi-Aventis, GlaxoSmithKline, and Viatris.
PBS and regulatory activity
Seven brands have PBAC outcomes on record, with the latest outcome dated 1 July 2025. Nine brands have AusPARs on record, with the latest AusPAR dated 4 June 2025.